In an environment marked by shifting interest-rate expectations, sector rotation, and renewed scrutiny of high-flying growth names, large-cap value ETFs have moved back into focus. SCHV and VTV are two of the most widely followed vehicles in this category, and they compete directly for the same investor goal: broad, inexpensive exposure to established U.S. companies trading at comparatively attractive valuations. Although their underlying indexes differ, the two funds hold substantial overlap and similar sector tilts. This ETF comparison examines their structural differences, sector exposure, cost profiles, and relative positioning to help investors understand where the two strategies converge and where they diverge. I also checked this using Tickeron’s AI Screener to see how the funds compare to others in the category.
The Schwab U.S. Large-Cap Value ETF (SCHV) is a passively managed fund that seeks to track the total return of the Dow Jones U.S. Large-Cap Value Total Stock Market Index. Launched in December 2009, it holds approximately 570 stocks spanning the large-cap value segment of the U.S. equity market. With an expense ratio of 0.04%, it ranks among the cheapest funds in the large-cap value category and manages roughly $15 billion in assets.
Its largest positions include Berkshire Hathaway, JPMorgan Chase, Exxon Mobil, Johnson & Johnson, Walmart, and AbbVie. Financials represent the largest sector weighting at roughly 20% of the portfolio, followed by technology, healthcare, and industrials. SCHV also retains meaningful energy and consumer staples exposure. The fund rebalances in line with its index and uses a market-capitalization-weighted, value-oriented selection methodology, resulting in a broadly diversified, large-cap tilt.
The Vanguard Value ETF (VTV) is a passively managed fund that seeks to track the CRSP U.S. Large Cap Value Index. Launched in January 2004, it is one of the oldest and largest value ETFs in the market, with roughly $180 billion in assets and an expense ratio of just 0.03%. The fund holds about 320 stocks, a more concentrated portfolio than SCHV's, and skews toward the very largest U.S. value names.
Its top holdings overlap heavily with SCHV, including Berkshire Hathaway, JPMorgan Chase, Exxon Mobil, Johnson & Johnson, and Walmart, with Micron Technology ranking as the single largest position. Financials lead the sector allocation at roughly 21–23%, followed by healthcare, industrials, and technology. VTV's healthcare weighting is notably higher than SCHV's, while its technology allocation is somewhat lower. This concentration in large, financially stable companies gives VTV a slightly higher weighted average market cap and a marginally lower overall portfolio beta.
Both funds sit at the intersection of several dominant market themes. Expectations around Federal Reserve interest-rate policy, inflation, and economic growth continue to influence the relative appeal of value versus growth. Financial stocks, the largest weight in both ETFs, are sensitive to the shape of the yield curve and credit conditions, while energy and industrials respond to commodity prices, capital-expenditure cycles, and global trade dynamics. Healthcare remains a steady defensive anchor, and the presence of semiconductor names such as Micron Technology links both funds to the artificial-intelligence and memory-chip demand cycle. As investors have rotated toward more reasonably valued, cash-generating businesses, capital flows into large-cap value strategies have strengthened. The principal sector risks include cyclical downturns in financials, energy price volatility, and concentrated exposure to a handful of dominant mega-cap names.
Over recent weeks and recent market cycles, both SCHV and VTV have generally moved in tandem, reflecting their substantial overlap and shared value orientation. Relative positioning, however, has been shaped by subtle differences in sector exposure. VTV's larger healthcare and financials allocation has provided somewhat different risk characteristics than SCHV's broader, more diversified basket, which includes a slightly higher number of mid-sized holdings. During periods when semiconductor and technology value names outperformed, SCHV's wider tech footprint offered incremental participation; conversely, VTV's tilt toward healthcare and its heavier concentration in mega-cap names tended to moderate volatility. Overall, VTV's scale and lower fee give it a marginal structural cost advantage, while SCHV's greater breadth offers slightly broader diversification. Neither fund has shown a persistent, decisive edge, as their performance drivers remain closely aligned.
When I review options like these, I often turn to Tickeron’s AI Screener to filter large-cap value funds by expense ratio, sector weights, and liquidity metrics. The platform lets me quickly compare holdings overlap and identify which strategy aligns best with a given risk tolerance or market view. It has become a regular part of my process for narrowing down ETF choices without spending hours on manual data pulls.
Based on observable structural factors, the edge appears to rest with VTV for most cost- and scale-sensitive investors. Its 0.03% expense ratio, enormous liquidity, and long track record provide a marginal structural edge, while its heavier allocation to healthcare and mega-cap value leaders offers a slightly more defensive profile amid ongoing macroeconomic uncertainty. That said, SCHV remains an exceptionally strong alternative, distinguished by broader diversification across roughly 570 holdings and a slightly wider technology footprint that may capture more upside during semiconductor-led rallies. The distinction is narrow: VTV leads on cost efficiency, liquidity, and concentration in established leaders, while SCHV leads on breadth. Investors prioritizing minimal cost and scale may lean toward VTV; those seeking greater diversification may prefer SCHV.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The RSI Indicator for SCHV moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 22 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on SCHV as a result. In 65 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for SCHV just turned positive on October 06, 2026. Looking at past instances where SCHV's MACD turned positive, the stock continued to rise in 42 of 52 cases over the following month. The odds of a continued upward trend are 81%.
SCHV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SCHV crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +0.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHV advanced for three days, in 279 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
SCHV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for SCHV entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue